In order to predict progression of CKD in patients with chronic heart failure, Jungbauer et al. (2016) evaluated urinary NAG, NGAL and KIM-1 concentrations in 149 patients, who were followed for a period of 5 years. This evidence concerns the gene LCN2 and chronic kidney disease.